IBDEI06N ; ; 19-NOV-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8699,1,5,0)
 ;;=5^Hemolytic Anemia,Microang
 ;;^UTILITY(U,$J,358.3,8699,2)
 ;;=^293664
 ;;^UTILITY(U,$J,358.3,8700,0)
 ;;=280.9^^44^541^86
 ;;^UTILITY(U,$J,358.3,8700,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8700,1,4,0)
 ;;=4^280.9
 ;;^UTILITY(U,$J,358.3,8700,1,5,0)
 ;;=5^Iron Defic Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,8700,2)
 ;;=^276946
 ;;^UTILITY(U,$J,358.3,8701,0)
 ;;=285.1^^44^541^84
 ;;^UTILITY(U,$J,358.3,8701,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8701,1,4,0)
 ;;=4^285.1
 ;;^UTILITY(U,$J,358.3,8701,1,5,0)
 ;;=5^Iron Defic Anemia d/t Acute Blood Loss
 ;;^UTILITY(U,$J,358.3,8701,2)
 ;;=^267986
 ;;^UTILITY(U,$J,358.3,8702,0)
 ;;=280.0^^44^541^85
 ;;^UTILITY(U,$J,358.3,8702,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8702,1,4,0)
 ;;=4^280.0
 ;;^UTILITY(U,$J,358.3,8702,1,5,0)
 ;;=5^Iron Defic Anemia d/t Chronic Blood Loss
 ;;^UTILITY(U,$J,358.3,8702,2)
 ;;=^267971
 ;;^UTILITY(U,$J,358.3,8703,0)
 ;;=281.9^^44^541^107
 ;;^UTILITY(U,$J,358.3,8703,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8703,1,4,0)
 ;;=4^281.9
 ;;^UTILITY(U,$J,358.3,8703,1,5,0)
 ;;=5^Nutritional Anemia
 ;;^UTILITY(U,$J,358.3,8703,2)
 ;;=^123801
 ;;^UTILITY(U,$J,358.3,8704,0)
 ;;=281.0^^44^541^123
 ;;^UTILITY(U,$J,358.3,8704,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8704,1,4,0)
 ;;=4^281.0
 ;;^UTILITY(U,$J,358.3,8704,1,5,0)
 ;;=5^Vit B12 Deficiency (Pernicious Anemia)
 ;;^UTILITY(U,$J,358.3,8704,2)
 ;;=^7161
 ;;^UTILITY(U,$J,358.3,8705,0)
 ;;=282.60^^44^541^111
 ;;^UTILITY(U,$J,358.3,8705,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8705,1,4,0)
 ;;=4^282.60
 ;;^UTILITY(U,$J,358.3,8705,1,5,0)
 ;;=5^Sickle-Cell Anemia
 ;;^UTILITY(U,$J,358.3,8705,2)
 ;;=^7188
 ;;^UTILITY(U,$J,358.3,8706,0)
 ;;=282.62^^44^541^112
 ;;^UTILITY(U,$J,358.3,8706,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8706,1,4,0)
 ;;=4^282.62
 ;;^UTILITY(U,$J,358.3,8706,1,5,0)
 ;;=5^Sickle-Cell With Crisis
 ;;^UTILITY(U,$J,358.3,8706,2)
 ;;=^267982
 ;;^UTILITY(U,$J,358.3,8707,0)
 ;;=281.1^^44^541^124
 ;;^UTILITY(U,$J,358.3,8707,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8707,1,4,0)
 ;;=4^281.1
 ;;^UTILITY(U,$J,358.3,8707,1,5,0)
 ;;=5^Vit B12 Deficiency(Dietary)
 ;;^UTILITY(U,$J,358.3,8707,2)
 ;;=^267974
 ;;^UTILITY(U,$J,358.3,8708,0)
 ;;=286.7^^44^541^54
 ;;^UTILITY(U,$J,358.3,8708,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8708,1,4,0)
 ;;=4^286.7
 ;;^UTILITY(U,$J,358.3,8708,1,5,0)
 ;;=5^Coagulation Defect(Any),Acquired
 ;;^UTILITY(U,$J,358.3,8708,2)
 ;;=^2235
 ;;^UTILITY(U,$J,358.3,8709,0)
 ;;=289.9^^44^541^120
 ;;^UTILITY(U,$J,358.3,8709,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8709,1,4,0)
 ;;=4^289.9
 ;;^UTILITY(U,$J,358.3,8709,1,5,0)
 ;;=5^Thrombocytosis, Essential
 ;;^UTILITY(U,$J,358.3,8709,2)
 ;;=^55344
 ;;^UTILITY(U,$J,358.3,8710,0)
 ;;=451.9^^44^541^121
 ;;^UTILITY(U,$J,358.3,8710,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8710,1,4,0)
 ;;=4^451.9
 ;;^UTILITY(U,$J,358.3,8710,1,5,0)
 ;;=5^Thrombophlebitis 
 ;;^UTILITY(U,$J,358.3,8710,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,8711,0)
 ;;=446.6^^44^541^122
 ;;^UTILITY(U,$J,358.3,8711,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8711,1,4,0)
 ;;=4^446.6
 ;;^UTILITY(U,$J,358.3,8711,1,5,0)
 ;;=5^Thrombotic Thrombocytopenic Purpura(Ttp)
 ;;^UTILITY(U,$J,358.3,8711,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,8712,0)
 ;;=286.4^^44^541^125
 ;;^UTILITY(U,$J,358.3,8712,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8712,1,4,0)
 ;;=4^286.4
 ;;^UTILITY(U,$J,358.3,8712,1,5,0)
 ;;=5^Von Willebrand's Disease
 ;;^UTILITY(U,$J,358.3,8712,2)
 ;;=^127267
 ;;^UTILITY(U,$J,358.3,8713,0)
 ;;=204.00^^44^541^1
 ;;^UTILITY(U,$J,358.3,8713,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8713,1,4,0)
 ;;=4^204.00
 ;;^UTILITY(U,$J,358.3,8713,1,5,0)
 ;;=5^ALL w/o Remission
 ;;^UTILITY(U,$J,358.3,8713,2)
 ;;=^267521
 ;;^UTILITY(U,$J,358.3,8714,0)
 ;;=204.01^^44^541^3
 ;;^UTILITY(U,$J,358.3,8714,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8714,1,4,0)
 ;;=4^204.01
 ;;^UTILITY(U,$J,358.3,8714,1,5,0)
 ;;=5^ALL,In Remission
 ;;^UTILITY(U,$J,358.3,8714,2)
 ;;=^267522
 ;;^UTILITY(U,$J,358.3,8715,0)
 ;;=204.10^^44^541^16
 ;;^UTILITY(U,$J,358.3,8715,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8715,1,4,0)
 ;;=4^204.10
 ;;^UTILITY(U,$J,358.3,8715,1,5,0)
 ;;=5^CLL w/o Remission
 ;;^UTILITY(U,$J,358.3,8715,2)
 ;;=^267523
 ;;^UTILITY(U,$J,358.3,8716,0)
 ;;=204.11^^44^541^18
 ;;^UTILITY(U,$J,358.3,8716,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8716,1,4,0)
 ;;=4^204.11
 ;;^UTILITY(U,$J,358.3,8716,1,5,0)
 ;;=5^CLL,In Remission
 ;;^UTILITY(U,$J,358.3,8716,2)
 ;;=^267524
 ;;^UTILITY(U,$J,358.3,8717,0)
 ;;=201.90^^44^541^83
 ;;^UTILITY(U,$J,358.3,8717,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8717,1,4,0)
 ;;=4^201.90
 ;;^UTILITY(U,$J,358.3,8717,1,5,0)
 ;;=5^Hodgkin's Lymphoma, Unpsec Type & Site
 ;;^UTILITY(U,$J,358.3,8717,2)
 ;;=^267430
 ;;^UTILITY(U,$J,358.3,8718,0)
 ;;=785.6^^44^541^89
 ;;^UTILITY(U,$J,358.3,8718,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8718,1,4,0)
 ;;=4^785.6
 ;;^UTILITY(U,$J,358.3,8718,1,5,0)
 ;;=5^Lymphadenopathy
 ;;^UTILITY(U,$J,358.3,8718,2)
 ;;=^72368
 ;;^UTILITY(U,$J,358.3,8719,0)
 ;;=200.20^^44^541^90
 ;;^UTILITY(U,$J,358.3,8719,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8719,1,4,0)
 ;;=4^200.20
 ;;^UTILITY(U,$J,358.3,8719,1,5,0)
 ;;=5^Lymphoma,Burkitt's,Site Unspec
 ;;^UTILITY(U,$J,358.3,8719,2)
 ;;=^17529
 ;;^UTILITY(U,$J,358.3,8720,0)
 ;;=202.00^^44^541^92
 ;;^UTILITY(U,$J,358.3,8720,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8720,1,4,0)
 ;;=4^202.00
 ;;^UTILITY(U,$J,358.3,8720,1,5,0)
 ;;=5^Lymphoma,Low-Grade,Site Unspec
 ;;^UTILITY(U,$J,358.3,8720,2)
 ;;=^72606
 ;;^UTILITY(U,$J,358.3,8721,0)
 ;;=200.10^^44^541^91
 ;;^UTILITY(U,$J,358.3,8721,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8721,1,4,0)
 ;;=4^200.10
 ;;^UTILITY(U,$J,358.3,8721,1,5,0)
 ;;=5^Lymphoma,Int or High Grade,Site Unspec
 ;;^UTILITY(U,$J,358.3,8721,2)
 ;;=^175886
 ;;^UTILITY(U,$J,358.3,8722,0)
 ;;=273.3^^44^541^93
 ;;^UTILITY(U,$J,358.3,8722,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8722,1,4,0)
 ;;=4^273.3
 ;;^UTILITY(U,$J,358.3,8722,1,5,0)
 ;;=5^Macroglobulinemia
 ;;^UTILITY(U,$J,358.3,8722,2)
 ;;=^73013
 ;;^UTILITY(U,$J,358.3,8723,0)
 ;;=203.00^^44^541^103
 ;;^UTILITY(U,$J,358.3,8723,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8723,1,4,0)
 ;;=4^203.00
 ;;^UTILITY(U,$J,358.3,8723,1,5,0)
 ;;=5^Multiple Myeloma w/o Remission
 ;;^UTILITY(U,$J,358.3,8723,2)
 ;;=^267514
 ;;^UTILITY(U,$J,358.3,8724,0)
 ;;=203.01^^44^541^105
 ;;^UTILITY(U,$J,358.3,8724,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8724,1,4,0)
 ;;=4^203.01
 ;;^UTILITY(U,$J,358.3,8724,1,5,0)
 ;;=5^Multiple Myeloma,In Remission
 ;;^UTILITY(U,$J,358.3,8724,2)
 ;;=^267515
 ;;^UTILITY(U,$J,358.3,8725,0)
 ;;=238.6^^44^541^108
 ;;^UTILITY(U,$J,358.3,8725,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8725,1,4,0)
 ;;=4^238.6
 ;;^UTILITY(U,$J,358.3,8725,1,5,0)
 ;;=5^Plasmacytoma NOS
 ;;^UTILITY(U,$J,358.3,8725,2)
 ;;=^81973
 ;;^UTILITY(U,$J,358.3,8726,0)
 ;;=205.00^^44^541^4
 ;;^UTILITY(U,$J,358.3,8726,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8726,1,4,0)
 ;;=4^205.00
 ;;^UTILITY(U,$J,358.3,8726,1,5,0)
 ;;=5^AML w/o Remission
 ;;^UTILITY(U,$J,358.3,8726,2)
 ;;=^267531
 ;;^UTILITY(U,$J,358.3,8727,0)
 ;;=205.01^^44^541^6
 ;;^UTILITY(U,$J,358.3,8727,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8727,1,4,0)
 ;;=4^205.01
 ;;^UTILITY(U,$J,358.3,8727,1,5,0)
 ;;=5^AML,In Remission
 ;;^UTILITY(U,$J,358.3,8727,2)
 ;;=^267532
 ;;^UTILITY(U,$J,358.3,8728,0)
 ;;=205.10^^44^541^19
 ;;^UTILITY(U,$J,358.3,8728,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8728,1,4,0)
 ;;=4^205.10
 ;;^UTILITY(U,$J,358.3,8728,1,5,0)
 ;;=5^CML w/o Remission
 ;;^UTILITY(U,$J,358.3,8728,2)
 ;;=^267533
 ;;^UTILITY(U,$J,358.3,8729,0)
 ;;=205.11^^44^541^21
 ;;^UTILITY(U,$J,358.3,8729,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8729,1,4,0)
 ;;=4^205.11
 ;;^UTILITY(U,$J,358.3,8729,1,5,0)
 ;;=5^CML,In Remission
 ;;^UTILITY(U,$J,358.3,8729,2)
 ;;=^267534
 ;;^UTILITY(U,$J,358.3,8730,0)
 ;;=289.0^^44^541^55
 ;;^UTILITY(U,$J,358.3,8730,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8730,1,4,0)
 ;;=4^289.0
 ;;^UTILITY(U,$J,358.3,8730,1,5,0)
 ;;=5^Erthryocytosis, Secondary
 ;;^UTILITY(U,$J,358.3,8730,2)
 ;;=^186856
 ;;^UTILITY(U,$J,358.3,8731,0)
 ;;=238.4^^44^541^109
 ;;^UTILITY(U,$J,358.3,8731,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8731,1,4,0)
 ;;=4^238.4
 ;;^UTILITY(U,$J,358.3,8731,1,5,0)
 ;;=5^Polycytheria Rubra Vera
 ;;^UTILITY(U,$J,358.3,8731,2)
 ;;=^96105
 ;;^UTILITY(U,$J,358.3,8732,0)
 ;;=V58.61^^44^541^126
 ;;^UTILITY(U,$J,358.3,8732,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8732,1,4,0)
 ;;=4^V58.61
 ;;^UTILITY(U,$J,358.3,8732,1,5,0)
 ;;=5^Warfarin/Coumadin Use
 ;;^UTILITY(U,$J,358.3,8732,2)
 ;;=Warfarin/Coumadin Use^303459
 ;;^UTILITY(U,$J,358.3,8733,0)
 ;;=282.49^^44^541^117
 ;;^UTILITY(U,$J,358.3,8733,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8733,1,4,0)
 ;;=4^282.49
 ;;^UTILITY(U,$J,358.3,8733,1,5,0)
 ;;=5^Thalassemia NEC
 ;;^UTILITY(U,$J,358.3,8733,2)
 ;;=^329910
 ;;^UTILITY(U,$J,358.3,8734,0)
 ;;=289.89^^44^541^15
 ;;^UTILITY(U,$J,358.3,8734,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8734,1,4,0)
 ;;=4^289.89
 ;;^UTILITY(U,$J,358.3,8734,1,5,0)
 ;;=5^Blood Diseases NEC
 ;;^UTILITY(U,$J,358.3,8734,2)
 ;;=^329887
 ;;^UTILITY(U,$J,358.3,8735,0)
 ;;=238.79^^44^541^88
 ;;^UTILITY(U,$J,358.3,8735,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8735,1,4,0)
 ;;=4^238.79
 ;;^UTILITY(U,$J,358.3,8735,1,5,0)
 ;;=5^Lymph/Hematopoietic Tissue NEC
 ;;^UTILITY(U,$J,358.3,8735,2)
 ;;=^334033
 ;;^UTILITY(U,$J,358.3,8736,0)
 ;;=287.30^^44^541^110
 ;;^UTILITY(U,$J,358.3,8736,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8736,1,4,0)
 ;;=4^287.30
 ;;^UTILITY(U,$J,358.3,8736,1,5,0)
 ;;=5^Primary Thrombocytopenia
 ;;^UTILITY(U,$J,358.3,8736,2)
 ;;=^332841
 ;;^UTILITY(U,$J,358.3,8737,0)
 ;;=288.09^^44^541^8
